Bausch Health Companies Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
BHC on NYSE
Industry
Pharmaceutical Preparations
Location
2150 St. Elzear Blvd. West, Laval, Quebec, Quebec, Canada

Insiders trading volume in the past year

Bausch Health Companies Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas Appio Chief Executive Officer, Director $21.6M Aug 30, 2024
Joseph C. Papa Director $11.4M May 10, 2022
Tom G. Vadaketh EVP, Chief Financial Officer $8.48M Sep 5, 2023
Seana Carson EVP, General Counsel $7.6M -$147K -1.9% Sep 5, 2024
Robert Spurr President, U.S. Businesses $5.13M May 10, 2022
Sam Eldessouky EVP & Chief Financial Officer $4.88M Mar 3, 2022
Richard U. De Schutter Director $3.11M Mar 31, 2023
Russel C. Robertson Director $2.39M Mar 29, 2024
Robert N. Power Director $2.13M May 17, 2024
Steven D. Miller Director $1.96M May 17, 2024
Sarah B. Kavanagh Director $1.93M May 17, 2024
Jean-Jacques Charhon Evp, Cfo $1.77M Aug 19, 2024
John Paulson Director $1.76M Jun 28, 2024
John S. Barresi SVP, Controller & CAO $1.64M Sep 5, 2024
Amy B. Wechsler Director $1.44M Jun 28, 2024
Christina Ackermann Evp And General Counsel $1.3M Mar 10, 2022
Thomas W. Sr. Ross Director $1.3M May 19, 2023
Richard Mulligan Director $1.07M May 17, 2024
Brett Icahn Director $1.04M Jun 28, 2024
Aimee J. Lenar EVP, US Pharma $1.01M Jul 15, 2024
Argeris N. Karabelas Director $992K Jun 24, 2022
Joseph F. Gordon Pres&Co-Head Bausch&Lomb/Int'l $747K Mar 8, 2022
Christian A. Garcia Director $375K May 17, 2024
Frank D. Lee Director $375K May 17, 2024
Andrew Von Eschenbach Director $310K Aug 5, 2021
Frederick Munsch SVP, Controller and CAO $180K May 3, 2022

Recent Insider Transactions by Companies or Individuals for Bausch Health Companies Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.